Talk Biomarkers & Precision Medicine Trials track
Using Gen AI for Content Extraction from ICFs to Ensure Compliance for Individual Site and Country to Meet Sample Destruction Timelines
Tue, Feb 4, 2025 · 4:40–5:05 PM EST Rosen Shingle Creek
About this session
Generative AI used to extract country and site-specific sample retention timelines from individual ICFs across sponsored clinical trials resulting in a user-friendly dashboard created to document differences in sample retention timelines and to ensure compliance with sample destruction for all subjects. Using a sample destruction countdown feature, end users can see upcoming sample expiration dates and ensure sample destruction approvals and actions are completed and documented appropriately.
